Business Description
Duopharma Biotech Bhd
ISIN : MYL7148OO009
Compare
Compare
Traded in other countries / regions
7148.Malaysia IPO Date
2002-07-18Description
Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer and exporter of pharmaceutical products and medicines.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.48 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.87 | |||||
| Debt-to-EBITDA | 4.69 | |||||
| Interest Coverage | 5.94 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.31 | |||||
| Beneish M-Score | -2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.5 | |||||
| 3-Year EBITDA Growth Rate | 5.1 | |||||
| 3-Year EPS without NRI Growth Rate | 5.6 | |||||
| 3-Year Book Growth Rate | 5.8 | |||||
| Future 3-5Y Total Revenue Growth Rate | 7.02 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.02 | |||||
| 9-Day RSI | 37.52 | |||||
| 14-Day RSI | 39.02 | |||||
| 6-1 Month Momentum % | -3.25 | |||||
| 12-1 Month Momentum % | -23.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.15 | |||||
| Quick Ratio | 1.39 | |||||
| Cash Ratio | 0.85 | |||||
| Days Inventory | 211.8 | |||||
| Days Sales Outstanding | 90.29 | |||||
| Days Payable | 94.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.02 | |||||
| Dividend Payout Ratio | 0.36 | |||||
| 3-Year Dividend Growth Rate | -15.4 | |||||
| Forward Dividend Yield % | 2.02 | |||||
| 5-Year Yield-on-Cost % | 2.65 | |||||
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | -3.01 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 39.99 | |||||
| Operating Margin % | 12.15 | |||||
| Net Margin % | 8.9 | |||||
| FCF Margin % | -1.42 | |||||
| ROE % | 9.24 | |||||
| ROA % | 4.86 | |||||
| ROIC % | 7.35 | |||||
| ROC (Joel Greenblatt) % | 9.87 | |||||
| ROCE % | 8.76 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.12 | |||||
| Forward PE Ratio | 15.63 | |||||
| PE Ratio without NRI | 18.12 | |||||
| Shiller PE Ratio | 16.09 | |||||
| PEG Ratio | 2.32 | |||||
| PS Ratio | 1.61 | |||||
| PB Ratio | 1.66 | |||||
| Price-to-Tangible-Book | 1.78 | |||||
| Price-to-Operating-Cash-Flow | 28.3 | |||||
| EV-to-EBIT | 16.62 | |||||
| EV-to-EBITDA | 11.31 | |||||
| EV-to-Forward-EBITDA | 9.02 | |||||
| EV-to-Revenue | 2.07 | |||||
| EV-to-Forward-Revenue | 1.8 | |||||
| EV-to-FCF | -147.84 | |||||
| Price-to-Projected-FCF | 2.97 | |||||
| Price-to-DCF (Earnings Based) | 1.57 | |||||
| Price-to-Median-PS-Value | 0.83 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.14 | |||||
| Price-to-Graham-Number | 1.2 | |||||
| Price-to-Net-Current-Asset-Value | 116 | |||||
| Earnings Yield (Greenblatt) % | 6.02 | |||||
| FCF Yield % | -0.88 | |||||
| Forward Rate of Return (Yacktman) % | 4.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Duopharma Biotech Bhd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil RM) | 689.186 | ||
| EPS (TTM) (RM) | 0.064 | ||
| Beta | 0.78 | ||
| Volatility % | 16.28 | ||
| 14-Day RSI | 39.02 | ||
| 14-Day ATR (RM) | 0.021846 | ||
| 20-Day SMA (RM) | 1.1945 | ||
| 12-1 Month Momentum % | -23.23 | ||
| 52-Week Range (RM) | 1.11 - 1.55 | ||
| Shares Outstanding (Mil) | 961.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Duopharma Biotech Bhd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Duopharma Biotech Bhd Stock Events
| Event | Date | Price(RM) | ||
|---|---|---|---|---|
| No Event Data | ||||
Duopharma Biotech Bhd Frequently Asked Questions
What is Duopharma Biotech Bhd(XKLS:7148)'s stock price today?
The current price of XKLS:7148 is RM1.16. The 52 week high of XKLS:7148 is RM1.55 and 52 week low is RM1.11.
When is next earnings date of Duopharma Biotech Bhd(XKLS:7148)?
The next earnings date of Duopharma Biotech Bhd(XKLS:7148) is .
Does Duopharma Biotech Bhd(XKLS:7148) pay dividends? If so, how much?
The Dividend Yield %  of Duopharma Biotech Bhd(XKLS:7148) is 2.02% (As of Today), Highest Dividend Payout Ratio of Duopharma Biotech Bhd(XKLS:7148) was 0.84. The lowest was 0.32. And the median was 0.65. The  Forward Dividend Yield % of Duopharma Biotech Bhd(XKLS:7148) is 2.02%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers